Breathe Well Live Well
|
Asthma and COPD Therapies Market Forecast 2014-2024: Opportunities for …
PR Newswire (press release) Where's the asthma and COPD therapies market heading? Visiongain's brand new report shows you potential revenues to 2024, assessing data, trends, opportunities and prospects there. Our 335-page report provides 264 tables, charts, and graphs. Discover … |
View full post on asthma – Google News
|
Nebulizers, Inhalers and Respirators for Asthma Treatment: Global Markets
PR Newswire (press release) The report is a comprehensive business tool designed to provide an in-depth look at equipment related to asthma. The report is global in geographical scope, with special emphasis on individual regions. The report describes the industry, its … |
View full post on asthma – Google News
|
Practice Fusion and AstraZeneca Partner on Population Health Management …
PR Newswire (press release) The program, developed by Practice Fusion and sponsored by AstraZeneca, identifies patients whose current asthma or COPD care does not meet evidence-based clinical guidelines, and then alerts physicians at the point of care via patient charts within … Aseptika secures US patent for its innovative respiratory infection test |
View full post on asthma – Google News
|
A Competitive Analysis of the Global Asthma and COPD Therapeutics Market …
PR Newswire (press release) oBenralizumab, a monoclonal antibody jointly being developed by MedImmune and AstraZeneca in Phase 3 trials. Benralizumab is bound to the interleukin-5 receptor (IL-5R?) and is being evaluated to help asthma control and reduce the onset of asthmatic … |
View full post on asthma – Google News
PR Newswire (press release) |
Asthma Triggers: Hiding in Plain Sight
PR Newswire (press release) CHICAGO, March 9, 2015 /PRNewswire-USNewswire/ — One in 12 Americans has asthma, according to the Centers for Disease Control and Prevention. While we don't know what causes asthma, we know what can lead to an asthma attack: exposure to … |
View full post on asthma – Google News
WHSV |
Allergy & Asthma Network Celebrates 30-Year Anniversary
PR Newswire (press release) VIENNA, Va., March 2, 2015 /PRNewswire-USNewswire/ — The past 30 years have seen dramatic changes in how asthma and allergies are diagnosed, treated and perceived by patients and their families. Allergy & Asthma Network (The Network) has been at … Breastfeeding may lower infant's allergy risk Doctors Preparing For the Upcoming Allergy Season |
View full post on asthma – Google News
|
New Phase III Data in Asthma Patients Show Tiotropium Improves Lung Function …
PR Newswire (press release) HOUSTON, Feb. 21, 2015 /PRNewswire/ — Boehringer Ingelheim today presented data on investigational tiotropium delivered via Respimat® inhaler from five Phase III trials from the UniTinA-asthma® program at the 2015 American Academy of Allergy, … |
View full post on asthma – Google News
|
Global COPD and Asthma Devices Market (Product Types and Geography …
PR Newswire (press release) The COPD and Asthma hold the largest market share within the global respiratory diseases' market. As estimated by Global Initiative for Asthma (GINA), approximately 300 million people suffer from Asthma globally. COPD was the 3rd leading cause for … |
View full post on asthma – Google News
|
Asthma Treatment Market (Drug) Worth $23 Billion by 2023
PR Newswire (press release) ReportsnReports.com adds PharmaPoint: Asthma – Global Drug Forecast and Market Analysis to 2023 research report that says asthma treatment market value will grow across eight major countries (the US, UK, France, Germany, Spain, Italy, Japan, and … |
View full post on asthma – Google News
|
COPD and Asthma Devices Market is Expected to Reach $34.3 Billion, Global …
PR Newswire (press release) According to a new report by Allied Market Research titled, "Global COPD and Asthma Devices Market – Size, Industry Analysis, Trends, Opportunities, Growth and Forecast, 2013 – 2020", the global COPD and asthma devices market would reach $34.3 billion … |
View full post on asthma – Google News